GlycosBio » Press Releases

News Category

Glycos Biotechnologies to Present at BIO’s Seventh Annual World Congress on Industrial Biotechnology and Bioprocessing

Glycos Biotechnologies’ SAB Chairman Presented Award for Research Converting Glycerine into High Value Products

Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generation bioproducts, today announced that Dr. Ramon Gonzalez, Scientific Advisory Board Chairman of GlycosBio, has received the 2010 Glycerine Innovation Award during the Annual Meeting of the American Oil Chemists’ Society (AOCS). The award is sponsored annually by The Soap and Detergent Associate (SDA) and the National Biodiesel Board (NBB).

GlycosBio Presents at BIO International Convention

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today announced it is presenting at the BIO International Convention taking place May 3rd – 6th in Chicago, IL.

Glycos Biotechnologies Announces Partnership with Malaysian Bio-XCell Sdn. Bhd. to Build an Industrial Biochemical Plant and a Biotechnology Research and Development Facility

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today announced the company’s international expansion into Malaysia.

Glycos Biotechnologies Presents at CERAWEEK 2010

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations to produce sustainable biochemicals, today announced it is presenting at CERAWEEK 2010 taking place March 8 – 12th in Houston, TX. Selected by CERA as an “Energy Innovation Pioneer”, GlycosBio is participating on a panel showcasing emerging biofuels, efficiency and E&P companies offering “disruptive technologies” for the energy future.

GlycosBio Announces Successful Production of Biochemicals in Pilot Plant Size Environment

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations to produce sustainable biochemicals, today announced it has successfully produced lactic acid and advanced ethanol in a commercial size facility capable of producing up to 150,000 liters of chemicals. This is an important milestone for GlycosBio and represents a major step forward as the company works towards the worldwide commercialization of its technology.

Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Daniel J. Monticello, Ph.D., as Vice President, Research and Development. In this role, Dr. Monticello will be responsible for directing the lab operations for GlycosBio, including research, development and the overall efforts associated with scale-up and commercialization of GlycosBio’s proprietary microbe technology. In addition, Dr. Monticello will be responsible for overseeing GlycosBio’s ongoing demonstration and commercialization efforts in Latin America.

Glycos Biotechnologies Appoints Chief Executive Officer

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Rich Cilento as Chief Executive Officer (CEO). A Venture Advisor for DFJ Mercury and currently Executive Chairman for GlycosBio, Cilento will now be responsible for the daily operations of the company as CEO.

Glycos Biotechnologies Featured in Accenture Report as Offering Evolutionary Technology

Glycos Biotechnologies, Inc. Selected by AlwaysOn as a GoingGreen Top 100 Winner Recognized for game-changing technology and market value

Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generational bio-products, today announced that it has been chosen by AlwaysOn as one of the GoingGreen Top 100 Winners. Inclusion in the GoingGreen 100 signifies major developments in the creation of new business opportunities in the green technology industries. GlycosBio was specially selected by the AlwaysOn editorial team and industry experts spanning the globe for leading technologies based on a set of five criteria: innovation, market potential, commercialization, stakeholder value, and media buzz.